|
Baseline characteristics
|
Usual care group (n = 11)
|
Intervention group (n = 9)
|
|---|
|
Gender, n (%)
|
Male
|
4 (36)
|
2 (22)
|
|
Age, years, mean ± SD
| |
59 ± 14
|
63 ± 10
|
|
MUST score, n (%)
|
0
|
9 (82)
|
7 (78)
|
| |
1
|
1 (9)
|
0 (0)
|
| |
≥2
|
1 (9)
|
2 (22)
|
|
Primary tumour, n (%)
|
Gastrointestinal
|
5 (46)
|
3 (33)
|
| |
Breast cancer
|
2 (18)
|
2 (22)
|
| |
Gynecological
|
4 (36)
|
4 (44)
|
|
Metastases, n (%)
|
Yes
|
7 (64)
|
5 (56)
|
| |
No
|
4 (36)
|
4 (44)
|
|
Emetogenicity chemotherapy, n (%)
|
High
|
1 (9)
|
0 (0)
|
| |
Moderate
|
5 (46)
|
7 (78)
|
| |
Low
|
5 (46)
|
2 (22)
|
|
Chemotherapy schedule, n (%)
|
Two weekly
|
1 (9)
|
0 (0)
|
| |
Three weekly
|
10 (91)
|
9 (100)
|
|
Comorbidities, n (%)
|
None
|
5 (46)
|
3 (33)
|
| |
Diabetes
|
2 (18)
|
0 (0)
|
| |
Hypertension
|
2 (18)
|
1 (11)
|
| |
Cardiovascular
|
1 (9)
|
0 (0)
|
| |
Other
|
4 (36)
|
2 (22)
|
- MUST malnutrition universal screening tool, MUST 0: low risk of malnutrition, MUST 1 medium risk of malnutrition, MUST ≥2 high risk of malnutrition
